These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 38061634)

  • 21. Expanding Contraceptive Access for Women With Substance Use Disorders: Partnerships Between Public Health Departments and County Jails.
    McNeely CA; Hutson S; Sturdivant TL; Jabson JM; Isabell BS
    J Public Health Manag Pract; 2019; 25(3):229-237. PubMed ID: 30234670
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Substance use disorder approaches in US primary care clinics with national reputations as workforce innovators.
    O'Malley DM; Abraham CM; Lee HS; Rubinstein EB; Howard J; Hudson SV; Kieber-Emmons AM; Crabtree BF
    Fam Pract; 2022 Mar; 39(2):282-291. PubMed ID: 34423366
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medication for opioid use disorder treatment continuity post-release from jail: A qualitative study with community-based treatment providers.
    Stopka TJ; Rottapel RE; Ferguson WJ; Pivovarova E; Toro-Mejias LD; Friedmann PD; Evans EA
    Int J Drug Policy; 2022 Dec; 110():103803. PubMed ID: 35965159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Knowledge, attitudes, and acceptability of direct-acting antiviral hepatitis C treatment among people incarcerated in jail: A qualitative study.
    Akiyama MJ; Ross J; Rimawi F; Fox A; Jordan AO; Wiersema J; Litwin AH; Kaba F; MacDonald R
    PLoS One; 2020; 15(12):e0242623. PubMed ID: 33264311
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Racial Disparities in Access to and Utilization of Jail- and Community-Based Mental Health Treatment in 8 US Midwestern Jails in 2017.
    Hedden BJ; Comartin E; Hambrick N; Kubiak S
    Am J Public Health; 2021 Feb; 111(2):277-285. PubMed ID: 33351663
    [No Abstract]   [Full Text] [Related]  

  • 26. Characteristics of Substance Use Screening at Intake in a Sample of U.S. Jails.
    Bunting AM; Nowotny K; Farabee D; McNeely J; Beckwith CG
    J Health Care Poor Underserved; 2023; 34(1):180-191. PubMed ID: 37464488
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The relationship between community public health, behavioral health service accessibility, and mass incarceration.
    Ramezani N; Breno AJ; Mackey BJ; Viglione J; Cuellar AE; Johnson JE; Taxman FS
    BMC Health Serv Res; 2022 Jul; 22(1):966. PubMed ID: 35906627
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Jail-Based For-Profit Mental Health Providers and Treatment Engagement After Release.
    Kern LJ; Comartin EB; Nelson V; Kubiak SP
    Psychiatr Serv; 2024 Aug; 75(8):756-762. PubMed ID: 38477837
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recidivism and mortality after in-jail buprenorphine treatment for opioid use disorder.
    Evans EA; Wilson D; Friedmann PD
    Drug Alcohol Depend; 2022 Feb; 231():109254. PubMed ID: 35063323
    [TBL] [Abstract][Full Text] [Related]  

  • 30. "You can get a couple of ramen noodle packs for a Buspar
    Hughes PM; Carda-Auten J; DiRosa EA; Carpenter D; Rosen DL
    Res Social Adm Pharm; 2023 Sep; 19(9):1298-1306. PubMed ID: 37270327
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk profile and treatment needs of women in jail with co-occurring serious mental illness and substance use disorders.
    Nowotny KM; Belknap J; Lynch S; DeHart D
    Women Health; 2014; 54(8):781-95. PubMed ID: 25204664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Confined to Obscurity: Health Challenges of Pregnant Women in Jail.
    Rose SJ; LeBel TP
    Health Soc Work; 2020 Aug; 45(3):177-185. PubMed ID: 32746452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Transitions Clinic Network: Post Incarceration Addiction Treatment, Healthcare, and Social Support (TCN-PATHS): A hybrid type-1 effectiveness trial of enhanced primary care to improve opioid use disorder treatment outcomes following release from jail.
    Howell BA; Puglisi L; Clark K; Albizu-Garcia C; Ashkin E; Booth T; Brinkley-Rubinstein L; Fiellin DA; Fox AD; Maurer KF; Lin HJ; McCollister K; Murphy S; Morse DS; Shavit S; Wang K; Winkelman T; Wang EA
    J Subst Abuse Treat; 2021 Sep; 128():108315. PubMed ID: 33583610
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mental Healthcare Practices from Entry to Release across Southeastern Jails.
    DiRosa E; Van Deinse T; Cuddeback G; Murray-Lichtman A; Carda-Auten J; Rosen D
    Res Sq; 2024 Mar; ():. PubMed ID: 38586059
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Access to HIV care in jails: Perspectives from people living with HIV in North Carolina.
    Blue C; Buchbinder M; Brown ME; Bradley-Bull S; Rosen DL
    PLoS One; 2022; 17(1):e0262882. PubMed ID: 35073350
    [TBL] [Abstract][Full Text] [Related]  

  • 36. "And Then COVID Hits": A Qualitative Study of How Jails Adapted Services to Treat Opioid Use Disorder During COVID-19.
    Harrington C; Bailey A; Delorme E; Hano S; Evans EA
    Subst Use Misuse; 2023; 58(2):266-274. PubMed ID: 36510800
    [No Abstract]   [Full Text] [Related]  

  • 37. Staff Perceptions of Substance Use Disorder Treatment in VA Primary Care-Mental Health Integrated Clinics.
    Zubkoff L; Shiner B; Watts BV
    J Subst Abuse Treat; 2016 Nov; 70():44-49. PubMed ID: 27692187
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Jail-to-community treatment continuum for adults with co-occurring substance use and mental disorders: study protocol for a pilot randomized controlled trial.
    Van Dorn RA; Desmarais SL; Rade CB; Burris EN; Cuddeback GS; Johnson KL; Tueller SJ; Comfort ML; Mueser KT
    Trials; 2017 Aug; 18(1):365. PubMed ID: 28778175
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recovery schools for improving behavioral and academic outcomes among students in recovery from substance use disorders: a systematic review.
    Hennessy EA; Tanner-Smith EE; Finch AJ; Sathe N; Kugley S
    Campbell Syst Rev; 2018; 14(1):1-86. PubMed ID: 37131375
    [TBL] [Abstract][Full Text] [Related]  

  • 40. VA residential substance use disorder treatment program providers' perceptions of facilitators and barriers to performance on pre-admission processes.
    Ellerbe LS; Manfredi L; Gupta S; Phelps TE; Bowe TR; Rubinsky AD; Burden JL; Harris AH
    Addict Sci Clin Pract; 2017 Apr; 12(1):10. PubMed ID: 28372579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.